Journal article
Acute skeletal muscle wasting in patients with acute kidney injury requiring continuous kidney replacement therapy: A prospective multicenter study
Journal of critical care, Vol.89, 155142
10/2025
DOI: 10.1016/j.jcrc.2025.155142
PMCID: PMC12303733
PMID: 40513259
Abstract
Acute kidney injury (AKI) requiring continuous kidney replacement therapy (CKRT) has been hypothesized to increase the risk of developing intensive care unit-associated weakness (ICU-AW), but prospective data are lacking.PURPOSEAcute kidney injury (AKI) requiring continuous kidney replacement therapy (CKRT) has been hypothesized to increase the risk of developing intensive care unit-associated weakness (ICU-AW), but prospective data are lacking.This prospective observational study evaluated critically ill adults with AKI requiring CKRT at two U.S. academic hospitals. Using ultrasonography (US), we quantified changes in rectus femoris (RF) muscle mass and quality in the first week after CKRT initiation. At hospital discharge, we assessed for ICU-AW, physical function, and frailty.MATERIALS AND METHODSThis prospective observational study evaluated critically ill adults with AKI requiring CKRT at two U.S. academic hospitals. Using ultrasonography (US), we quantified changes in rectus femoris (RF) muscle mass and quality in the first week after CKRT initiation. At hospital discharge, we assessed for ICU-AW, physical function, and frailty.Twenty-three patients with median age 56 [IQR 47-60] years, BMI 29 [26-36] kg/m2, and Charlson Comorbidity Index 3 [1.5-5] were enrolled. The baseline Sequential Organ Failure Assessment (SOFA) score was 9 [7.5-11.5] and CKRT duration was 4 [1-7] days. Six (26 %) patients died in the ICU and one (4 %) transitioned to comfort measures before study completion. Substantial muscle wasting occurred between Day 1 and Day 7: RF muscle thickness (mT) decreased by 10 % [3 %-20 %]; RF cross-sectional area (CSA) decreased by 19 % [12 %-22 %]; and echo intensity (EI) increased (implying worse muscle quality) by 14 % [5 %-25 %]. A significant effect of time within subjects was observed for all three ultrasound measures (CSA: F = 66.2, p < 0.001; mT: F = 27.1, p < 0.001; EI: F = 22.5, p < 0.001). At hospital discharge, 67 % of survivors (n = 10/15) met criteria for ICU-AW.RESULTSTwenty-three patients with median age 56 [IQR 47-60] years, BMI 29 [26-36] kg/m2, and Charlson Comorbidity Index 3 [1.5-5] were enrolled. The baseline Sequential Organ Failure Assessment (SOFA) score was 9 [7.5-11.5] and CKRT duration was 4 [1-7] days. Six (26 %) patients died in the ICU and one (4 %) transitioned to comfort measures before study completion. Substantial muscle wasting occurred between Day 1 and Day 7: RF muscle thickness (mT) decreased by 10 % [3 %-20 %]; RF cross-sectional area (CSA) decreased by 19 % [12 %-22 %]; and echo intensity (EI) increased (implying worse muscle quality) by 14 % [5 %-25 %]. A significant effect of time within subjects was observed for all three ultrasound measures (CSA: F = 66.2, p < 0.001; mT: F = 27.1, p < 0.001; EI: F = 22.5, p < 0.001). At hospital discharge, 67 % of survivors (n = 10/15) met criteria for ICU-AW.Patients with AKI requiring CKRT experienced significant muscle wasting in the first week following CKRT initiation and had high rate of ICU-AW at hospital discharge.CONCLUSIONSPatients with AKI requiring CKRT experienced significant muscle wasting in the first week following CKRT initiation and had high rate of ICU-AW at hospital discharge.NCT05287204, Registered 20 October 2021.TRIAL REGISTRATIONNCT05287204, Registered 20 October 2021.
Details
- Title: Subtitle
- Acute skeletal muscle wasting in patients with acute kidney injury requiring continuous kidney replacement therapy: A prospective multicenter study
- Creators
- Kirby P MayerJ Pedro TeixeiraFelipe González-SeguelVinh Q TranJessica M GrossArimitsu Horikawa-StrakovskyChaitanya Anil PalZan T ShareefHayley Puffer IsraelYuan WenBenjamin R GriffinJavier A Neyra
- Resource Type
- Journal article
- Publication Details
- Journal of critical care, Vol.89, 155142
- DOI
- 10.1016/j.jcrc.2025.155142
- PMID
- 40513259
- PMCID
- PMC12303733
- NLM abbreviation
- J Crit Care
- ISSN
- 1557-8615
- eISSN
- 1557-8615
- Publisher
- Elsevier
- Grant note
- NIH National Center for Advancing Translational Sciences: UL1TR001998 National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institute of Health: AR079583
The project was supported by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998. Dr. Mayer was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institute of Health AR079583. The content is solely the responsibility of the authors does not necessarily represent the official views of the NIH.
- Language
- English
- Electronic publication date
- 06/11/2025
- Date published
- 10/2025
- Academic Unit
- Nephrology; Internal Medicine
- Record Identifier
- 9984829888302771
Metrics
4 Record Views